Gilead Sciences, Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 11, 2010

Gilead Sciences, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 0-19731 94-3047598
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
333 Lakeside Drive, Foster City, California   94404
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   650-574-3000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Top of the Form

SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.07   Submission of Matters to a Vote of Security Holders

The 2010 annual meeting of the stockholders of Gilead Sciences, Inc. (Gilead) was held on May 11, 2010 in Millbrae, California. Of the 902,033,996 shares of our common stock entitled to vote at the meeting, 759,666,323 shares were represented at the meeting in person or by proxy, constituting a quorum. The voting results are presented below.

Our stockholders elected 13 directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal. The votes regarding the election of directors were as follows:

                         
Name   Shares Voted For   Votes Withheld   Broker Non-Vote
Paul Berg.................................................
    681,219,401       8,772,296       69,674,626  
John F. Cogan..........................................
    688,044,910       1,946,787       69,674,626  
Etienne F. Davignon....................................
    678,587,273       11,404,424       69,674,626  
James M. Denny.......................................
    678,694,512       11,297,185       69,674,626  
Carla A. Hills..........................................
    686,629,067       3,362,630       69,674,626  
Kevin E. Lofton.......................................
    687,270,671       2,721,026       69,674,626  
John W. Madigan........................................
    686,128,348       3,863,349       69,674,626  
John C. Martin...........................................
    673,494,855       16,496,842       69,674,626  
Gordon E. Moore........................................
    677,880,753       12,110,944       69,674,626  
Nicholas G. Moore....................................
    686,171,844       3,819,853       69,674,626  
Richard J. Whitley....................................
    680,636,373       9,355,324       69,674,626  
Gayle E. Wilson.......................................
    687,420,314       2,571,383       69,674,626  
Per Wold-Olsen.......................................
    680,592,518       9,399,179       69,674,626  

Our stockholders ratified the selection of Ernst & Young LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2010. There were 746,535,143 votes cast for the proposal, 12,146,723 votes cast against, 984,457 abstentions and no broker non-votes.

Our stockholders approved a stockholder proposal requesting the Board of Directors take steps to adopt majority voting standards in Gilead’s certificate of incorporation and by-laws. There were 572,282,889 votes cast for the proposal, 116,960,161 votes cast against, 748,647 abstentions and 69,674,626 broker non-votes.


Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Gilead Sciences, Inc.
          
May 14, 2010   By:   /s/ Robin L. Washington
       
        Name: Robin L. Washington
        Title: Senior Vice President and Chief Financial Officer